Capricor Therapeutics Stock (NASDAQ: CAPR) stock price, news, charts, stock research, profile.
Open | $4.72 |
Close | $4.77 |
Volume / Avg. | 4.27M / 357.70K |
Day Range | 4.64 - 5.25 |
52 Wk Range | 2.68 - 8.22 |
Market Cap | $152.86M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 16.97% |
Days to Cover | 12.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.
Other companies in Capricor Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
There is no analysis for Capricor Therapeutics.
Capricor Therapeutics has a consensus price target of $21.75.
The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $4.78 last updated June 28, 2024 at 5:28 PM EDT.
There are no upcoming dividends for Capricor Therapeutics.
Capricor Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Capricor Therapeutics.
Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.